Literature DB >> 27554474

Systematic Functional Characterization of Candidate Causal Genes for Type 2 Diabetes Risk Variants.

Soren K Thomsen1, Alessandro Ceroni2, Martijn van de Bunt1,3, Carla Burrows1, Amy Barrett1, Raphael Scharfmann4, Daniel Ebner2, Mark I McCarthy1,3,5, Anna L Gloyn6,3,5.   

Abstract

Most genetic association signals for type 2 diabetes risk are located in noncoding regions of the genome, hindering translation into molecular mechanisms. Physiological studies have shown a majority of disease-associated variants to exert their effects through pancreatic islet dysfunction. Systematically characterizing the role of regional transcripts in β-cell function could identify the underlying disease-causing genes, but large-scale studies in human cellular models have previously been impractical. We developed a robust and scalable strategy based on arrayed gene silencing in the human β-cell line EndoC-βH1. In a screen of 300 positional candidates selected from 75 type 2 diabetes regions, each gene was assayed for effects on multiple disease-relevant phenotypes, including insulin secretion and cellular proliferation. We identified a total of 45 genes involved in β-cell function, pointing to possible causal mechanisms at 37 disease-associated loci. The results showed a strong enrichment for genes implicated in monogenic diabetes. Selected effects were validated in a follow-up study, including several genes (ARL15, ZMIZ1, and THADA) with previously unknown or poorly described roles in β-cell biology. We have demonstrated the feasibility of systematic functional screening in a human β-cell model and successfully prioritized plausible disease-causing genes at more than half of the regions investigated.
© 2016 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27554474      PMCID: PMC5402869          DOI: 10.2337/db16-0361

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  25 in total

1.  A genetically engineered human pancreatic β cell line exhibiting glucose-inducible insulin secretion.

Authors:  Philippe Ravassard; Yasmine Hazhouz; Séverine Pechberty; Emilie Bricout-Neveu; Mathieu Armanet; Paul Czernichow; Raphael Scharfmann
Journal:  J Clin Invest       Date:  2011-08-25       Impact factor: 14.808

2.  Identification of glucose-dependant insulin secretion targets in pancreatic beta cells by combining defined-mechanism compound library screening and siRNA gene silencing.

Authors:  Weizhen Wu; Jin Shang; Yue Feng; Chris M Thompson; Sarah Horwitz; John R Thompson; Euan D MacIntyre; Nancy A Thornberry; Kevin Chapman; Yun-Ping Zhou; Andrew D Howard; Jing Li
Journal:  J Biomol Screen       Date:  2008-01-23

3.  Global genomic and transcriptomic analysis of human pancreatic islets reveals novel genes influencing glucose metabolism.

Authors:  João Fadista; Petter Vikman; Emilia Ottosson Laakso; Inês Guerra Mollet; Jonathan Lou Esguerra; Jalal Taneera; Petter Storm; Peter Osmark; Claes Ladenvall; Rashmi B Prasad; Karin B Hansson; Francesca Finotello; Kristina Uvebrant; Jones K Ofori; Barbara Di Camillo; Ulrika Krus; Corrado M Cilio; Ola Hansson; Lena Eliasson; Anders H Rosengren; Erik Renström; Claes B Wollheim; Leif Groop
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-08       Impact factor: 11.205

4.  An siRNA screen in pancreatic beta cells reveals a role for Gpr27 in insulin production.

Authors:  Gregory M Ku; Zachary Pappalardo; Chun Chieh Luo; Michael S German; Michael T McManus
Journal:  PLoS Genet       Date:  2012-01-12       Impact factor: 5.917

5.  Type 2 diabetes: hypoinsulinism, hyperinsulinism, or both?

Authors:  Benjamin Glaser
Journal:  PLoS Med       Date:  2007-04       Impact factor: 11.069

6.  Characterization of stimulus-secretion coupling in the human pancreatic EndoC-βH1 beta cell line.

Authors:  Lotta E Andersson; Bérengère Valtat; Annika Bagge; Vladimir V Sharoyko; David G Nicholls; Philippe Ravassard; Raphael Scharfmann; Peter Spégel; Hindrik Mulder
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

7.  Transcript Expression Data from Human Islets Links Regulatory Signals from Genome-Wide Association Studies for Type 2 Diabetes and Glycemic Traits to Their Downstream Effectors.

Authors:  Martijn van de Bunt; Jocelyn E Manning Fox; Xiaoqing Dai; Amy Barrett; Caleb Grey; Lei Li; Amanda J Bennett; Paul R Johnson; Raymond V Rajotte; Kyle J Gaulton; Emmanouil T Dermitzakis; Patrick E MacDonald; Mark I McCarthy; Anna L Gloyn
Journal:  PLoS Genet       Date:  2015-12-01       Impact factor: 5.917

8.  The pancreatic β cell: recent insights from human genetics.

Authors:  Soren K Thomsen; Anna L Gloyn
Journal:  Trends Endocrinol Metab       Date:  2014-06-28       Impact factor: 12.015

9.  Gene variants in the novel type 2 diabetes loci CDC123/CAMK1D, THADA, ADAMTS9, BCL11A, and MTNR1B affect different aspects of pancreatic beta-cell function.

Authors:  Annemarie M Simonis-Bik; Giel Nijpels; Timon W van Haeften; Jeanine J Houwing-Duistermaat; Dorret I Boomsma; Erwin Reiling; Els C van Hove; Michaela Diamant; Mark H H Kramer; Robert J Heine; J Antonie Maassen; P Eline Slagboom; Gonneke Willemsen; Jacqueline M Dekker; Elisabeth M Eekhoff; Eco J de Geus; Leen M 't Hart
Journal:  Diabetes       Date:  2009-10-15       Impact factor: 9.461

10.  Loss-of-Function Mutations in the Cell-Cycle Control Gene CDKN2A Impact on Glucose Homeostasis in Humans.

Authors:  Aparna Pal; Thomas P Potjer; Soren K Thomsen; Hui Jin Ng; Amy Barrett; Raphael Scharfmann; Tim J James; D Timothy Bishop; Fredrik Karpe; Ian F Godsland; Hans F A Vasen; Julia Newton-Bishop; Hanno Pijl; Mark I McCarthy; Anna L Gloyn
Journal:  Diabetes       Date:  2015-11-05       Impact factor: 9.461

View more
  42 in total

Review 1.  Melatonin receptors: molecular pharmacology and signalling in the context of system bias.

Authors:  Erika Cecon; Atsuro Oishi; Ralf Jockers
Journal:  Br J Pharmacol       Date:  2017-08-17       Impact factor: 8.739

Review 2.  Deciphering the Emerging Complexities of Molecular Mechanisms at GWAS Loci.

Authors:  Maren E Cannon; Karen L Mohlke
Journal:  Am J Hum Genet       Date:  2018-11-01       Impact factor: 11.025

3.  The case for too little melatonin signalling in increased diabetes risk.

Authors:  Amélie Bonnefond; Philippe Froguel
Journal:  Diabetologia       Date:  2017-03-17       Impact factor: 10.122

4.  Epigenetics and Epigenomics: Implications for Diabetes and Obesity.

Authors:  Evan D Rosen; Klaus H Kaestner; Rama Natarajan; Mary-Elizabeth Patti; Richard Sallari; Maike Sander; Katalin Susztak
Journal:  Diabetes       Date:  2018-10       Impact factor: 9.461

Review 5.  Genomics of Islet (Dys)function and Type 2 Diabetes.

Authors:  Nathan Lawlor; Shubham Khetan; Duygu Ucar; Michael L Stitzel
Journal:  Trends Genet       Date:  2017-02-27       Impact factor: 11.639

Review 6.  Disentangling the Role of Melatonin and its Receptor MTNR1B in Type 2 Diabetes: Still a Long Way to Go?

Authors:  Amélie Bonnefond; Philippe Froguel
Journal:  Curr Diab Rep       Date:  2017-10-23       Impact factor: 4.810

7.  Functional Screening of Candidate Causal Genes for Insulin Resistance in Human Preadipocytes and Adipocytes.

Authors:  Zhifen Chen; Haojie Yu; Xu Shi; Curtis R Warren; Luca A Lotta; Max Friesen; Torsten B Meissner; Claudia Langenberg; Martin Wabitsch; Nick Wareham; Mark D Benson; Rob E Gerszten; Chad A Cowan
Journal:  Circ Res       Date:  2019-11-19       Impact factor: 17.367

Review 8.  Mechanisms of Type 2 Diabetes Risk Loci.

Authors:  Kyle J Gaulton
Journal:  Curr Diab Rep       Date:  2017-09       Impact factor: 4.810

Review 9.  Insights into pancreatic islet cell dysfunction from type 2 diabetes mellitus genetics.

Authors:  Nicole A J Krentz; Anna L Gloyn
Journal:  Nat Rev Endocrinol       Date:  2020-02-25       Impact factor: 43.330

10.  Commutative regulation between endothelial NO synthase and insulin receptor substrate 2 by microRNAs.

Authors:  Xiaoli Sun; Huizhen Lv; Peng Zhao; Jinlong He; Qinghua Cui; Minxin Wei; Shiqing Feng; Yi Zhu
Journal:  J Mol Cell Biol       Date:  2019-06-01       Impact factor: 6.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.